Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ryan Olav Benjamin

In-Vivo Comparison of Thorium-227 and Zirconium-89 Labeled 3,2-Hopo Mesothelin Antibody-Chelator Conjugate

Journal of Medical Imaging and Radiation Sciences

Radiological

Radiology

Nuclear Medicine

Ultrasound Technology

Imaging

2019

English

Related publications

Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination With DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models

Journal of Nuclear Medicine

English

Effect of Chelator Conjugation Level and Injection Dose on Tumor and Organ Uptake of 111In-Labeled MORAb-009, an Anti-Mesothelin Antibody

Nuclear Medicine and Biology

English

In Vitro and in Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia

Molecular Cancer Therapeutics

Cancer Research

Oncology

2016

English

Zirconium-89 Labeled Panitumumab: A Potential Immuno-Pet Probe for HER1-expressing Carcinomas

Nuclear Medicine and Biology

English

in Vivo Chelation of Am(III), Pu(IV), Np(V), and U(VI) in Mice by TREN-(Me-3,2-HOPO)

Radiation Protection Dosimetry

Nuclear Medicine

Radiology

Ultrasound Technology

English

Preclinical Efficacy of a PSMA-targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer

Clinical Cancer Research

Cancer Research

Oncology

2019

English

New Methodology for the Preparation of 3-Hydroxy-2-Pyridinone (3,2-Hopo) Chelators and Extractants. Part 2: Reactions of Alcohols, Phenols, and Thiols With an Electrophilic 3,2-Hopo Reagent

English

Functional Relevance of in Vivo Half Antibody Exchange of an IgG4 Therapeutic Antibody-Drug Conjugate

PLoS ONE

Multidisciplinary

2018

English

Zirconium-89 Chloride Can Be Used for Immuno-Pet Radiochemistry Without Loss of Antigen Reactivity in Vivo

Journal of Nuclear Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ryan Olav Benjamin

In-Vivo Comparison of Thorium-227 and Zirconium-89 Labeled 3,2-Hopo Mesothelin Antibody-Chelator Conjugate

Related publications

Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination With DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models

Effect of Chelator Conjugation Level and Injection Dose on Tumor and Organ Uptake of 111In-Labeled MORAb-009, an Anti-Mesothelin Antibody

In Vitro and in Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia

Zirconium-89 Labeled Panitumumab: A Potential Immuno-Pet Probe for HER1-expressing Carcinomas

in Vivo Chelation of Am(III), Pu(IV), Np(V), and U(VI) in Mice by TREN-(Me-3,2-HOPO)

Preclinical Efficacy of a PSMA-targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer

New Methodology for the Preparation of 3-Hydroxy-2-Pyridinone (3,2-Hopo) Chelators and Extractants. Part 2: Reactions of Alcohols, Phenols, and Thiols With an Electrophilic 3,2-Hopo Reagent

Functional Relevance of in Vivo Half Antibody Exchange of an IgG4 Therapeutic Antibody-Drug Conjugate

Zirconium-89 Chloride Can Be Used for Immuno-Pet Radiochemistry Without Loss of Antigen Reactivity in Vivo